Opesinkast 4 OPV prevent and treat chronic bronchial asthma (3 blisters x 10 tablets)

Dosage form Box of 3 blisters x 10 tablets
Specifications Montelukast

Ingredient

Composition information	Content
Montelukast	4mg

Uses

indications

Opesinkast 4 drug is indicated for treatment in the following cases:

Preventive and treat chronic bronchial asthma for adults and children from 6 months of age and older, including preventing day and night asthma symptoms, treating asthma sensitive to Aspirin and preventing bronchial attacks due to exertion. 6 months of age).

pharmacokinetics

No data.

Before taking Opesinkast 4 OPV prevent and treat chronic bronchial asthma (3 blisters x 10 tablets)

How to use

Opesinkast is taken once a day at full or hungry. To treat asthma, should take medicine in the evening. With allergic rhinitis, the time to use the drug depends on the needs of each patient. For patients who have both asthma and allergic rhinitis, should take 1 capsule every day in the evening.

Dosage

Patients aged 15 and older with asthma and/or allergic rhinitis

1 tablet daily 10 mg or 2 tablets 5 mg.

Children 6 to 14 years old have asthma and/or allergic rhinitis

1 tablet daily 5 mg.

Children 2 to 5 years old with asthma and allergic rhinitis

1 tablet daily 4 mg.

Children from 6 months to 2 years old have asthma and/or allergic rhinitis all year round

1 tablet daily 4 mg.

General recommendation

Opesinkast's treatment effect on asthma test parameters will achieve pharmaceuticals within 1 day. It is necessary to tell patients to continue using Opesinkast despite the control of asthma, as well as in periods of severe asthma.

No dose adjustment for patients with renal impairment, mild and medium liver failure, elderly people, or for each gender.

Opesinkast treatment is related to other asthma drugs

Opesinkast can be used in combination with other treatments.

Dose of combined drugs

Bronchodilators, inhaled or oral corticosteroids. Do not sudden replacement of inhaled corticosteroids or drinking with opesinkast.

Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What to do when using overdose?

What to do when you forget 1 dose? However, if the time to relax with the next dose is too short, skip the dose and continue the calendar of the drug. Do not use double dose to compensate for missed dose.

Side Effects

When using opesinkast, you may experience unwanted effects (ADR).

Very common, ADR ≥ 1/10

Bacterial infection: upper respiratory infection.

Common, 1/100 ≤ ADR Digestive: diarrhea, nausea, vomiting.

immune: Hypersensitivity reaction includes anaphylaxis. Orange.

Blood: tends to increase bleeding.

immunity: Eosin hyperburger in the liver. Red spots, diverse roses.

Instructions on how to handle ADR

consult your doctor if you have unwanted effects when using the drug.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

contraindicated

Opesinkast drugs contraindicated in the following cases:

There is a history of sensitivity to the ingredients of the drug.

Be cautious when using

If asthma or shortness of breath is getting worse, it is necessary to notify the doctor immediately.

Do not use Montelukast oral forms to treat acute asthma attacks. Patients should be instructed to take the appropriate drugs available.

can reduce inhaled corticosteroids gradually with the supervision of a doctor, but must not suddenly replace corticosteroid oral or inhaling with Montelukast.

Must be vigilant with any signs of Churg - Strauss syndrome.

Do not take aspirin or anti -inflammatory drugs (such as nonsteroidal anti -inflammatory drugs) if they make asthma attack worse.

There is no study of the safety and effectiveness of the drug in children under 6 months old.

Use drugs for women during pregnancy and lactation

pregnancy

Not studied in pregnant people. Montelukast is only used during pregnancy if you have carefully considered.

Breastfeeding period

It is unclear whether Montelukast is excreted through breast milk or not. Therefore, this drug can only be used for breastfeeding women if considered carefully.

The effect of drugs on driving and operating machinery

There is no basis to prove Montelukast affects the ability to drive or operate machinery. However, some side effects (such as dizziness and drowsiness) have been reported very rare that can affect the ability to drive or operate machinery of some patients.

Medicinal interaction

can be used Montelukast with other commonly used drugs in preventive and chronic treatment of asthma and allergic rhinitis treatment. In drug interactive studies, Montelukast's clinical recommendations do not significantly affect the pharmacokinetics of the following drugs: Theophyllin, Prednison, Prednisolon, Oral contraceptive drugs (Norethindron 1mg /ethinyylestradiol 35MCG), Terfenadin, Digoxin and Warfarin.Montelukast's under the curve (AUC) area decreased by about 40% in users simultaneously with phenobarbital. Because Montelukast is metabolized by CYP 3A4, it is necessary to be cautious, especially in children when Montelukast used simultaneously with drugs metabolized by CYP 3A4 such as Phenytoin, Phenobarbital and Rifampicin.

Storage

Leave a cool place, avoid light, temperature below 30⁰C.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.